Jane Street’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $789K | Sell |
54,424
-80,344
| -60% | -$933K | ﹤0.01% | 7010 |
|
|
2025
Q4 | $1.3M | Buy |
134,768
+85,029
| +171% | +$814K | ﹤0.01% | 5614 |
|
|
2025
Q3 | $468K | Buy |
49,739
+26,868
| +117% | +$257K | ﹤0.01% | 8012 |
|
|
2025
Q2 | $242K | Buy |
22,871
+5,488
| +32% | +$69.2K | ﹤0.01% | 8219 |
|
|
2025
Q1 | $261K | Sell |
17,383
-10,033
| -37% | -$167K | ﹤0.01% | 8032 |
|
|
2024
Q4 | $451K | Buy |
27,416
+3,065
| +13% | +$60.5K | ﹤0.01% | 6992 |
|
|
2024
Q3 | $601K | Buy |
24,351
+8,550
| +54% | +$222K | ﹤0.01% | 6869 |
|
|
2024
Q2 | $400K | Buy |
15,801
+6,849
| +77% | +$178K | ﹤0.01% | 7366 |
|
|
2024
Q1 | $227K | Sell |
8,952
-7,601
| -46% | -$184K | ﹤0.01% | 7999 |
|
|
2023
Q4 | $375K | Sell |
16,553
-2,003
| -11% | -$41.4K | ﹤0.01% | 7274 |
|
|
2023
Q3 | $346K | Buy |
18,556
+3,735
| +25% | +$77.5K | ﹤0.01% | 6847 |
|
|
2023
Q2 | $385K | Buy |
+14,821
| New | +$397K | ﹤0.01% | 6718 |
|
|
2023
Q1 | – | Sell |
-9,151
| Closed | -$271K | – | 8961 |
|
|
2022
Q4 | $271K | Buy |
+9,151
| New | +$260K | ﹤0.01% | 7187 |
|
|
2021
Q2 | – | Sell |
-9,915
| Closed | -$404K | – | 9724 |
|
|
2021
Q1 | $404K | Buy |
+9,915
| New | +$376K | ﹤0.01% | 7186 |
|
|
2018
Q3 | – | Sell |
-9,508
| Closed | -$304K | – | 5038 |
|
|
2018
Q2 | $304K | Buy |
+9,508
| New | +$392K | ﹤0.01% | 4097 |
|
|
2014
Q4 | – | Sell |
-24,724
| Closed | -$906K | – | 2446 |
|
|
2014
Q3 | $906K | Buy |
+24,724
| New | +$1.07M | 0.02% | 993 |
|
|
2014
Q2 | – | Sell |
-39,868
| Closed | -$1.64M | – | 2514 |
|
|
2014
Q1 | $1.64M | Buy |
+39,868
| New | +$1.48M | 0.03% | 645 |
|
|
2013
Q4 | – | Sell |
-19,521
| Closed | -$466K | – | 2306 |
|
|
2013
Q3 | $466K | Buy |
+19,521
| New | +$438K | 0.01% | 1765 |
|
Other funds holding ANIK
CP
VCM
BFM
CM
